Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 28;42(2):112058.
doi: 10.1016/j.celrep.2023.112058. Epub 2023 Feb 6.

Selective ablation of primary and paracrine senescent cells by targeting iron dyshomeostasis

Affiliations
Free article

Selective ablation of primary and paracrine senescent cells by targeting iron dyshomeostasis

Tesfahun Dessale Admasu et al. Cell Rep. .
Free article

Abstract

Senescent cells can spread the senescent phenotype to other cells by secreting senescence-associated secretory phenotype factors. The resulting paracrine senescent cells make a significant contribution to the burden of senescent cell accumulation with age. Previous efforts made to characterize paracrine senescence are unreliable due to analyses being based on mixed populations of senescent and non-senescent cells. Here, we use dipeptidyl peptidase-4 (DPP4) as a surface maker to isolate senescent cells from mixed populations. Using this technique, we enrich the percentage of paracrine senescence from 40% to 85%. We then use this enriched culture to characterize DPP4+ primary and paracrine senescent cells. We observe ferroptosis dysregulation and ferrous iron accumulation as a common phenomenon in both primary and paracrine senescent cells. Finally, we identify ferroptosis induction and ferrous iron-activatable prodrug as a broad-spectrum senolytic approach to ablate multiple types of primary and paracrine senescent cells.

Keywords: CP: Cell biology; ferroptosis; ferrous; iron; paracrine senescence; prodrug; senescence.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests J.P.M. is an advisor/consultant for the Longevity Vision Fund, NOVOS, Youth Bio Therapeutics, and the founder of Magellan Science Ltd, a company providing consulting services in longevity science. A.R.R. is a co-founder of Tatara Therapeutics Inc., which is developing iron-activated therapeutics.

Publication types

LinkOut - more resources